149 related articles for article (PubMed ID: 24701697)
21. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
22. The treatment of advanced colorectal cancer: where are we now and where do we go?
Van Cutsem E; Verslype C; Demedts I
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):319-30. PubMed ID: 11969241
[TBL] [Abstract][Full Text] [Related]
23. Personalized medicine in metastatic colorectal cancer treated with anti-epidermal growth factor receptor agents: a future opportunity?
Tejpar S; Piessevaux H
Asia Pac J Clin Oncol; 2014 Mar; 10 Suppl 1():2-10. PubMed ID: 24512508
[TBL] [Abstract][Full Text] [Related]
24. Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008.
Price TJ; Tebbutt NC; Karapetis CS; Segelov E; Pavlakis N; Cunningham D; Sobrero AF; Haller DG; Shapiro JD
Clin Colorectal Cancer; 2010 Jan; 9(1):8-14. PubMed ID: 20100683
[TBL] [Abstract][Full Text] [Related]
25. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.
Jain VK; Hawkes EA; Cunningham D
Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675
[TBL] [Abstract][Full Text] [Related]
26. [Systemic treatment of metastatic colorectal cancer].
Montemurro M; Achtari L; Röth A; Halkic N; Luthi F; Ozsahin M; Denys A; Bauer J; Demartines N; Leyvraz S
Rev Med Suisse; 2008 May; 4(158):1254-7. PubMed ID: 18616207
[TBL] [Abstract][Full Text] [Related]
27. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
28. Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer.
Asghar U; Hawkes E; Cunningham D
Clin Colorectal Cancer; 2010 Dec; 9(5):274-81. PubMed ID: 21208841
[TBL] [Abstract][Full Text] [Related]
29. Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer.
Macarulla T; Ramos FJ; Elez E; Capdevila J; Peralta S; Tabernero J
Clin Colorectal Cancer; 2008 Sep; 7(5):300-8. PubMed ID: 18794061
[TBL] [Abstract][Full Text] [Related]
30. What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting?
Al-Salama HM; Johnstone EC; Kerr DJ
Discov Med; 2009 Oct; 8(42):104-7. PubMed ID: 19833054
[TBL] [Abstract][Full Text] [Related]
31. The evolution of biomarkers to guide the treatment of metastatic colorectal cancer.
Davis LE
Am J Manag Care; 2018 Apr; 24(7 Suppl):S107-S117. PubMed ID: 30207665
[TBL] [Abstract][Full Text] [Related]
32. Personalizing prostate cancer therapy: the way forward.
Cetnar JP; Beer TM
Drug Discov Today; 2014 Sep; 19(9):1483-7. PubMed ID: 25046532
[TBL] [Abstract][Full Text] [Related]
33. Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer Management.
Lieu CH; Corcoran RB; Overman MJ
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():207-215. PubMed ID: 31099678
[TBL] [Abstract][Full Text] [Related]
34. An update on the current and emerging targeted agents in metastatic colorectal cancer.
Chu E
Clin Colorectal Cancer; 2012 Mar; 11(1):1-13. PubMed ID: 21752724
[TBL] [Abstract][Full Text] [Related]
35. Targeting FGF receptors in colorectal cancer: from bench side to bed side.
Abdel-Rahman O
Future Oncol; 2015; 11(9):1373-9. PubMed ID: 25952783
[TBL] [Abstract][Full Text] [Related]
36. Molecular Triage Trials in Colorectal Cancer.
O'Hara MH; Hamilton SR; O'Dwyer PJ
Cancer J; 2016; 22(3):218-22. PubMed ID: 27341602
[TBL] [Abstract][Full Text] [Related]
37. Metastatic colorectal cancer- third line therapy and beyond.
Foo T; Roy A; Karapetis C; Townsend A; Price T
Expert Rev Anticancer Ther; 2024 May; 24(5):219-227. PubMed ID: 38526540
[TBL] [Abstract][Full Text] [Related]
38. Optimal management of metastatic colorectal cancer: current status.
McRee AJ; Goldberg RM
Drugs; 2011 May; 71(7):869-84. PubMed ID: 21568364
[TBL] [Abstract][Full Text] [Related]
39. Optimizing biologic sequencing in metastatic colorectal cancer: first line and beyond.
Jin Z; Hubbard JM
Curr Oncol; 2019 Nov; 26(Suppl 1):S33-S42. PubMed ID: 31819708
[TBL] [Abstract][Full Text] [Related]
40. Molecular Biomarkers: A Review of Multiple Applications in Clinical Care of Colorectal Cancer.
Schmitt ML
Clin J Oncol Nurs; 2020 Dec; 24(6):635-643. PubMed ID: 33216064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
